Loading…

Placebo-controlled trial of essential fatty acid supplementation in atopic dermatitis

Treatment of atopic dermatitis with essential fatty acids remains controversial. A double-blind, placebo-controlled, parallel-group study was done to investigate the response of patients with atopic dermatitis to essential fatty acid supplements. Patients with atopic dermatitis were randomised to re...

Full description

Saved in:
Bibliographic Details
Published in:The Lancet (British edition) 1993-06, Vol.341 (8860), p.1557-1560
Main Authors: Berth-Jones, J., Graham-Brown, R.A.C.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c507t-40c076afc7f81e4500d6cf8dabdcd06bc95a670f9a23cdf986fdb10f705a39653
cites cdi_FETCH-LOGICAL-c507t-40c076afc7f81e4500d6cf8dabdcd06bc95a670f9a23cdf986fdb10f705a39653
container_end_page 1560
container_issue 8860
container_start_page 1557
container_title The Lancet (British edition)
container_volume 341
creator Berth-Jones, J.
Graham-Brown, R.A.C.
description Treatment of atopic dermatitis with essential fatty acids remains controversial. A double-blind, placebo-controlled, parallel-group study was done to investigate the response of patients with atopic dermatitis to essential fatty acid supplements. Patients with atopic dermatitis were randomised to receive evening primrose oil, evening primrose oil and fish oil, or placebo for 16 weeks. Disease activity was monitored by clinical severity scores recorded by the investigator, topical steroid requirement, and symptom scores recorded by subjects. Of 123 subjects recruited, 102 completed the treatment period. No improvement with active treatment was demonstrated. Our study, which avoided the methodological and analytical problems of previous studies, found no effect of essential fatty acid supplementation in atopic dermatitis.
doi_str_mv 10.1016/0140-6736(93)90697-F
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75780191</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>014067369390697F</els_id><sourcerecordid>1696648</sourcerecordid><originalsourceid>FETCH-LOGICAL-c507t-40c076afc7f81e4500d6cf8dabdcd06bc95a670f9a23cdf986fdb10f705a39653</originalsourceid><addsrcrecordid>eNp9kUGLFDEQhYMo67j6DxQaFdFDa2U6nXQugizOrrCgBxe8hXQlgSzpTpukhf33m3GGOQjuqUi9ryrFe4S8pPCRAuWfgDJouej4e9l9kMClaHePyIYywdqeiV-PyeaEPCXPcr4FAMahPyNnA0jJGWzIzY-g0Y6xxTiXFEOwpinJ69BE19ic7Vz2D6dLuWs0etPkdVmCnaqgi49z4-dGl7h4bIxNU-0Vn5-TJ06HbF8c6zm52X39eXHVXn-__Hbx5brFHkRpGSAIrh0KN1DLegDD0Q1GjwYN8BFlr7kAJ_W2Q-PkwJ0ZKTgBve4k77tz8u6wd0nx92pzUZPPaEPQs41rVqIXA1BJK_jmH_A2rmmut6kt7SnlA5NdpV7_j6JSAoX6ZYXYAcIUc07WqSX5Sac7RUHtg1F719XedSU79TcYtatjr46713Gy5jR0TKLqb4-6zqiDS3pGn08YE5JtQVbs8wGz1dY_3iaV0dsZrfHJYlEm-ofvuAeVZqmr</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>199010653</pqid></control><display><type>article</type><title>Placebo-controlled trial of essential fatty acid supplementation in atopic dermatitis</title><source>Access via Business Source (EBSCOhost)</source><creator>Berth-Jones, J. ; Graham-Brown, R.A.C.</creator><creatorcontrib>Berth-Jones, J. ; Graham-Brown, R.A.C.</creatorcontrib><description>Treatment of atopic dermatitis with essential fatty acids remains controversial. A double-blind, placebo-controlled, parallel-group study was done to investigate the response of patients with atopic dermatitis to essential fatty acid supplements. Patients with atopic dermatitis were randomised to receive evening primrose oil, evening primrose oil and fish oil, or placebo for 16 weeks. Disease activity was monitored by clinical severity scores recorded by the investigator, topical steroid requirement, and symptom scores recorded by subjects. Of 123 subjects recruited, 102 completed the treatment period. No improvement with active treatment was demonstrated. Our study, which avoided the methodological and analytical problems of previous studies, found no effect of essential fatty acid supplementation in atopic dermatitis.</description><identifier>ISSN: 0140-6736</identifier><identifier>EISSN: 1474-547X</identifier><identifier>DOI: 10.1016/0140-6736(93)90697-F</identifier><identifier>PMID: 8099640</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>London: Elsevier Ltd</publisher><subject>Adult ; Allergic diseases ; Anti-Inflammatory Agents, Non-Steroidal - administration &amp; dosage ; Anti-Inflammatory Agents, Non-Steroidal - therapeutic use ; Atopic dermatitis ; Biological and medical sciences ; Clinical trials ; Dermatitis ; Dermatitis, Atopic - drug therapy ; Double-Blind Method ; Drug Therapy, Combination ; Eczema ; Evening primrose oil ; Fatty acids ; Fatty Acids, Essential - administration &amp; dosage ; Fatty Acids, Essential - therapeutic use ; Female ; Fish oils ; Fish Oils - administration &amp; dosage ; Fish Oils - therapeutic use ; gamma-Linolenic Acid ; Humans ; Immunopathology ; Linoleic Acids ; Lipids ; Male ; Medical research ; Medical sciences ; Oils &amp; fats ; Patients ; Plant Oils ; Skin allergic diseases. Stinging insect allergies ; Supplements</subject><ispartof>The Lancet (British edition), 1993-06, Vol.341 (8860), p.1557-1560</ispartof><rights>1993</rights><rights>1993 INIST-CNRS</rights><rights>Copyright Lancet Ltd. Jun 19, 1993</rights><rights>Copyright Elsevier Limited Jun 19, 1993</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c507t-40c076afc7f81e4500d6cf8dabdcd06bc95a670f9a23cdf986fdb10f705a39653</citedby><cites>FETCH-LOGICAL-c507t-40c076afc7f81e4500d6cf8dabdcd06bc95a670f9a23cdf986fdb10f705a39653</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4794209$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8099640$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Berth-Jones, J.</creatorcontrib><creatorcontrib>Graham-Brown, R.A.C.</creatorcontrib><title>Placebo-controlled trial of essential fatty acid supplementation in atopic dermatitis</title><title>The Lancet (British edition)</title><addtitle>Lancet</addtitle><description>Treatment of atopic dermatitis with essential fatty acids remains controversial. A double-blind, placebo-controlled, parallel-group study was done to investigate the response of patients with atopic dermatitis to essential fatty acid supplements. Patients with atopic dermatitis were randomised to receive evening primrose oil, evening primrose oil and fish oil, or placebo for 16 weeks. Disease activity was monitored by clinical severity scores recorded by the investigator, topical steroid requirement, and symptom scores recorded by subjects. Of 123 subjects recruited, 102 completed the treatment period. No improvement with active treatment was demonstrated. Our study, which avoided the methodological and analytical problems of previous studies, found no effect of essential fatty acid supplementation in atopic dermatitis.</description><subject>Adult</subject><subject>Allergic diseases</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - administration &amp; dosage</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</subject><subject>Atopic dermatitis</subject><subject>Biological and medical sciences</subject><subject>Clinical trials</subject><subject>Dermatitis</subject><subject>Dermatitis, Atopic - drug therapy</subject><subject>Double-Blind Method</subject><subject>Drug Therapy, Combination</subject><subject>Eczema</subject><subject>Evening primrose oil</subject><subject>Fatty acids</subject><subject>Fatty Acids, Essential - administration &amp; dosage</subject><subject>Fatty Acids, Essential - therapeutic use</subject><subject>Female</subject><subject>Fish oils</subject><subject>Fish Oils - administration &amp; dosage</subject><subject>Fish Oils - therapeutic use</subject><subject>gamma-Linolenic Acid</subject><subject>Humans</subject><subject>Immunopathology</subject><subject>Linoleic Acids</subject><subject>Lipids</subject><subject>Male</subject><subject>Medical research</subject><subject>Medical sciences</subject><subject>Oils &amp; fats</subject><subject>Patients</subject><subject>Plant Oils</subject><subject>Skin allergic diseases. Stinging insect allergies</subject><subject>Supplements</subject><issn>0140-6736</issn><issn>1474-547X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><recordid>eNp9kUGLFDEQhYMo67j6DxQaFdFDa2U6nXQugizOrrCgBxe8hXQlgSzpTpukhf33m3GGOQjuqUi9ryrFe4S8pPCRAuWfgDJouej4e9l9kMClaHePyIYywdqeiV-PyeaEPCXPcr4FAMahPyNnA0jJGWzIzY-g0Y6xxTiXFEOwpinJ69BE19ic7Vz2D6dLuWs0etPkdVmCnaqgi49z4-dGl7h4bIxNU-0Vn5-TJ06HbF8c6zm52X39eXHVXn-__Hbx5brFHkRpGSAIrh0KN1DLegDD0Q1GjwYN8BFlr7kAJ_W2Q-PkwJ0ZKTgBve4k77tz8u6wd0nx92pzUZPPaEPQs41rVqIXA1BJK_jmH_A2rmmut6kt7SnlA5NdpV7_j6JSAoX6ZYXYAcIUc07WqSX5Sac7RUHtg1F719XedSU79TcYtatjr46713Gy5jR0TKLqb4-6zqiDS3pGn08YE5JtQVbs8wGz1dY_3iaV0dsZrfHJYlEm-ofvuAeVZqmr</recordid><startdate>19930619</startdate><enddate>19930619</enddate><creator>Berth-Jones, J.</creator><creator>Graham-Brown, R.A.C.</creator><general>Elsevier Ltd</general><general>Lancet</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TT</scope><scope>0TZ</scope><scope>0U~</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88C</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>KB~</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>19930619</creationdate><title>Placebo-controlled trial of essential fatty acid supplementation in atopic dermatitis</title><author>Berth-Jones, J. ; Graham-Brown, R.A.C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c507t-40c076afc7f81e4500d6cf8dabdcd06bc95a670f9a23cdf986fdb10f705a39653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Adult</topic><topic>Allergic diseases</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - administration &amp; dosage</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</topic><topic>Atopic dermatitis</topic><topic>Biological and medical sciences</topic><topic>Clinical trials</topic><topic>Dermatitis</topic><topic>Dermatitis, Atopic - drug therapy</topic><topic>Double-Blind Method</topic><topic>Drug Therapy, Combination</topic><topic>Eczema</topic><topic>Evening primrose oil</topic><topic>Fatty acids</topic><topic>Fatty Acids, Essential - administration &amp; dosage</topic><topic>Fatty Acids, Essential - therapeutic use</topic><topic>Female</topic><topic>Fish oils</topic><topic>Fish Oils - administration &amp; dosage</topic><topic>Fish Oils - therapeutic use</topic><topic>gamma-Linolenic Acid</topic><topic>Humans</topic><topic>Immunopathology</topic><topic>Linoleic Acids</topic><topic>Lipids</topic><topic>Male</topic><topic>Medical research</topic><topic>Medical sciences</topic><topic>Oils &amp; fats</topic><topic>Patients</topic><topic>Plant Oils</topic><topic>Skin allergic diseases. Stinging insect allergies</topic><topic>Supplements</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Berth-Jones, J.</creatorcontrib><creatorcontrib>Graham-Brown, R.A.C.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>News PRO</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Global News &amp; ABI/Inform Professional</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Newsstand Professional</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>ProQuest Research Library</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Berth-Jones, J.</au><au>Graham-Brown, R.A.C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Placebo-controlled trial of essential fatty acid supplementation in atopic dermatitis</atitle><jtitle>The Lancet (British edition)</jtitle><addtitle>Lancet</addtitle><date>1993-06-19</date><risdate>1993</risdate><volume>341</volume><issue>8860</issue><spage>1557</spage><epage>1560</epage><pages>1557-1560</pages><issn>0140-6736</issn><eissn>1474-547X</eissn><coden>LANCAO</coden><abstract>Treatment of atopic dermatitis with essential fatty acids remains controversial. A double-blind, placebo-controlled, parallel-group study was done to investigate the response of patients with atopic dermatitis to essential fatty acid supplements. Patients with atopic dermatitis were randomised to receive evening primrose oil, evening primrose oil and fish oil, or placebo for 16 weeks. Disease activity was monitored by clinical severity scores recorded by the investigator, topical steroid requirement, and symptom scores recorded by subjects. Of 123 subjects recruited, 102 completed the treatment period. No improvement with active treatment was demonstrated. Our study, which avoided the methodological and analytical problems of previous studies, found no effect of essential fatty acid supplementation in atopic dermatitis.</abstract><cop>London</cop><pub>Elsevier Ltd</pub><pmid>8099640</pmid><doi>10.1016/0140-6736(93)90697-F</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0140-6736
ispartof The Lancet (British edition), 1993-06, Vol.341 (8860), p.1557-1560
issn 0140-6736
1474-547X
language eng
recordid cdi_proquest_miscellaneous_75780191
source Access via Business Source (EBSCOhost)
subjects Adult
Allergic diseases
Anti-Inflammatory Agents, Non-Steroidal - administration & dosage
Anti-Inflammatory Agents, Non-Steroidal - therapeutic use
Atopic dermatitis
Biological and medical sciences
Clinical trials
Dermatitis
Dermatitis, Atopic - drug therapy
Double-Blind Method
Drug Therapy, Combination
Eczema
Evening primrose oil
Fatty acids
Fatty Acids, Essential - administration & dosage
Fatty Acids, Essential - therapeutic use
Female
Fish oils
Fish Oils - administration & dosage
Fish Oils - therapeutic use
gamma-Linolenic Acid
Humans
Immunopathology
Linoleic Acids
Lipids
Male
Medical research
Medical sciences
Oils & fats
Patients
Plant Oils
Skin allergic diseases. Stinging insect allergies
Supplements
title Placebo-controlled trial of essential fatty acid supplementation in atopic dermatitis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T09%3A07%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Placebo-controlled%20trial%20of%20essential%20fatty%20acid%20supplementation%20in%20atopic%20dermatitis&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=Berth-Jones,%20J.&rft.date=1993-06-19&rft.volume=341&rft.issue=8860&rft.spage=1557&rft.epage=1560&rft.pages=1557-1560&rft.issn=0140-6736&rft.eissn=1474-547X&rft.coden=LANCAO&rft_id=info:doi/10.1016/0140-6736(93)90697-F&rft_dat=%3Cproquest_cross%3E1696648%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c507t-40c076afc7f81e4500d6cf8dabdcd06bc95a670f9a23cdf986fdb10f705a39653%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=199010653&rft_id=info:pmid/8099640&rfr_iscdi=true